A sensitive, rapid, and label free magnetic bead aggregation (MBA) assay has been developed that employs superparamagnetic (SPM) beads to capture, purify, and detect model proteins and the herpes simplex virus (HSV). The MBA assay is based on monitoring the aggregation state of a population of SPM beads using light scattering of individual aggregates. A biotin-streptavidin MBA assay had a 10 femtomolar (fM) level sensitivity for analysis times less than 10 minutes, but the response of the assay becomes nonlinear at high analyte concentrations. A MBA assay for the detection of HSV-1 based on a novel peptide probe resulted in the selective detection of the virus at concentrations as low as 200 viral particles (vp) per mL in less than 30 min. We define the parameters that determine the sensitivity and response of the MBA assay, and the mechanism of enhanced sensitivity of the assay for HSV. The speed, 15 relatively low cost, and ease of application of the MBA assay promise to make it useful for the identification of viral load in resource-limited and point-of-care settings where molecular diagnostics cannot be easily implemented.
Introduction
HSV-1 and 2 are large (>150 kb), double-stranded DNA viruses 20 from the Herpesviridae family that are transmitted to humans by direct skin-to-skin contact, in the case of HSV-1 by contact with the orofacial region, and for HSV-2 through sexual routes. Between 60%-95% of adults worldwide are infected by herpes simplex virus. 1 Symptoms include sores or blisters around the 25 infected region, causing discomfort and in some cases, pain, for the individual. Although rare, HSV infection of the central nervous system can occur, resulting in herpes simplex encephalitis (HSE), which is fatal in 70% of untreated cases. 2 The clinical outcome of HSV infection can be favourable if antiviral 30 therapy is appointed in the early stages of infection, accentuating the need for rapid diagnostic assays. The gold standard HSV diagnostic test involves the monitoring of cytopathic effects of the virus on susceptible cell cultures. While highly sensitive and specific, results can take up to one week to 35 complete. 3 To circumvent time issues, polymerase chain reaction (PCR), has been proposed as an alternative diagnostic assay, which maintains high sensitivity and specificity, but requires trained personnel and remains time consuming (4h). 4 Other diagnostic procedures such as enzyme immunoassay (EIA) and 40 fluorescent antibody tests (FAT) typically take several hours to conduct and suffer from poor sensitivity. 5, 6 As a result, these tests are rarely used as the sole means of detection. To improve therapy uptake, new assays are needed to enable rapid diagnosis in a point of care (POC) setting. 45 Bioanalytical testing often requires a pretreatment stage involving filtration and/or purification. SPM beads, composed of assemblies of iron oxide nanoparticles, provide a rapid, efficient, and cost effective way to pre-concentrate or separate an analyte from complex materials to simplify and facilitate the front-end of 50 an assay. They are readily available through a number of synthetic strategies and commercial sources, 7 offering a range of chemistries suitable for separation. SPMs have demonstrated their versatility for use in conjunction with techniques such as the polymerase chain reaction 8 and mass spectroscopy, 9 and have 55 been utilized in high-throughput linear magnetophoresis (LM) assays. [10] [11] [12] [13] [14] Importantly, if the analyte contains multiple epitopes, it is possible for the target to bind to multiple beads simultaneously, leading to bead aggregation. 10, [15] [16] [17] Exploiting aggregation as an analytical signal allows for a simple, label-free 60 detection strategy. This process has been utilized in LM, allowing the detection of dengue virus as low as 10 plaque forming units/mL.
10
Central to any affinity-based detection is the choice of probe. Structurally, herpes simplex virus is highly complex, and 65 comprises three major structural elements, namely, the inner nucleo-capsid, the tegument, and the envelope on the exterior. The envelope has been shown to contain up to 750 glycoprotein spikes, varying in length, spacing and their protruding angles.
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This complexity makes the generation of affinity ligands 70 targeting HSV challenging. While antibodies remain the gold standard in immunodiagnostics, the viability of peptide-based viral diagnostic assays is being increasingly recognized.
19-21
Identification of peptide ligands by phage display technology, and subsequent production by solid phase peptide synthesis 75 (SPPS), offers an elegant and inexpensive alternative to the generation of antibody ligands, while maintaining affinity and specificity similar to naturally occurring protein-based ligands. Moreover, the synthetic nature of peptide ligands affords the option to improve and optimize interaction with the target through sequence variation. 22 Interestingly, reports suggest that the generation of multiple antigenic peptides (MAPs) enhances 5 binding of monovalent peptide counterparts, [23] [24] [25] due to the creation of an observed avidity effect when multiple binding events occur. In this article we describe the screening of a linear dodecameric peptide phage display library to identify novel peptide-based ligands for high affinity binding of HSV-1.
10 Figure 1 illustrates the principle of the MBA assay. The virus was first incubated with the peptide functionalized SPM beads, depicted in Figure 1B , and in the second step a magnetic gradient was applied to the bead suspension, to separate the beads and accelerate the rate of bead interaction. The ability to monitor 15 changes in size, as well as fluorescence, of individual bead aggregates makes flow cytometry (FC) an attractive technology platform for MBA assays. The magnetic separation procedure is rapid, and requires as little as 2 min with FC analysis producing sample sizes as high as 100,000 particles in 5 minutes. In this 20 article we describe the development and performance of MBA assays for a model biotin-streptavidin and subsequently HSV-1, defining sensitivity, response time, and the nonlinear response of the assay at high concentrations of analyte.
25 Figure 1 . MBA assay for HSV-1 based on single particle light scattering. A. Anti-HSV-1 SPM beads were incubated with HSV-1 and the aggregation of the beads was aided by the application of a magnetic field. The final aggregation state of the beads was determined using FC. B. Schematic of the capture of HSV-1 30 using peptide functionalized SPM beads and assembly of SPM bead aggregates as a result of magnetic aggregation. C. Chemistry used to modify the SPM beads with affinity ligands.
(1) Carboxyl beads were modified with a PEI monolayer, (2) a mixed BOC and methoxy-PEG monolayer was grafted onto this 35 amine-derivatized surface, (3) the BOC-PEGs were deprotected, and (4) the thiolated MAP was coupled to maleimide-activated NH 2 -PEGs.
Experimental Section
Peptide design, synthesis and characterization 40 The preparation of the bacteriophage library and screening has been described in the Supporting Information. Peptide selection was based on phage ELISA assays of clones selected against HSV-1 as described in the Supporting Information. The three identified linear dodecapeptides, i.e., N -NHVHRMHATPAY, E
45
-EHMALTYPFRPP and, G -GPKALSPLMRMG, were synthesized at >95 % purity (Entelechon, Germany). The Cterminus of these peptides was elongated with a GGGS-CONH 2 moiety to mimic the GGGS-peptide spacer between the random peptide sequence tethered to the bacteriophage pIII protein and to 50 block the negative charge of the carboxyl terminus. The ability of biotinylated synthetic peptides to bind purified HSV-1 was analyzed using a solid phase assay. In this case, 10 µg/mL of peptide in PBS buffer was incubated on HSV-coated wells (100 g/mL) and detected using a streptavidin-HRP conjugate. Binding 55 and absorbance readings were carried out using the TMB substrate as described previously. 32 For the aggregation assays, biotinylated and cysteine-terminated peptides, based on the best peptide candidate, were generated in a multimeric, branched format, i.e., (GPKALSPLMRMG) 4 -K 2 KGGS-K(Biotin) and 60 (GPKALSPLMRMG) 4 K 2 KGSGCG)).
Preparation of peptide and antibody functionalized SPMs
Three types of SPM beads were used in this study, i.e., streptavidin, antibody, or peptide functionalized beads. Anti-HSV functionalized beads were created by coupling the antibody to MAP-E, were prepared by incubating the biotinylated multimeric peptides at 2 mg/mL with streptavidin beads (3mg) in 1mL PBS buffer for 1 hour. After three washes with PBST (0.1%), the three different peptide-functionalized beads were stored until further use with 0.1 (wt/wt%) BSA at 4 o C. Two variations of the peptide 80 beads were generated by covalently coupling the peptides to PEG functionalized beads, i.e., SPM-G2 and SPM-G3, using the fourstep surface chemistry presented in Figure 1C . The carboxyl SPM beads were first functionalized with a primary amine monolayer using a two-step chemistry, i.e., 1 ml of carboxyl 85 coated beads (5 mg/mL) were activated with a solution of 5 mg EDC and 5 mg sulfo-NHS in 0.5 ml MES buffer; and these beads were reacted with a 1 ml solution of 5% PEI in carbonate buffer. The beads were then modified with a monolayer of PEG, i.e., a mixture of hetrobifunctional PEGs (10 mg/mL) in 0.6 M K 2 SO 4 90 was added to 1 ml of the amine modified beads and reacted for 2 h at 50°C. The ratio of BOC-NH-PEG-NHS and methoxy-PEG-NHS used was either 1:3 for the SPM-G2 beads or 1:0 for the SPM-G3 beads. The unreacted primary and secondary amines on the beads were then capped using a two-step procedure, i.e., the 95 beads were activated with 1 mg/ml of SMCC in a solution of 25% DMSO and 75% PBST for 1 hr, and the maleimide group was then capped by reacting the beads with 5% (V/V) mercaptoethanol in PBS 2 hrs. The deprotection of the primary amine was achieved by reacting the beads with 60% (v/v) trifluoroacetic acid (TFA) in PBST buffer. MAP-G with a terminal cysteine was then coupled to the beads using the sulfosuccinimidyl
carboxylate (SMCC) coupling chemistry. Each stage of the reaction was characterized with zeta potential measurements, as shown in Figure S4 .
Magnetic Bead Aggregation (MBA) Assay
Figures 1A and B illustrate the steps of the MBA assay and FC 10 analysis. Samples of HSV or BBSA were prepared by dilution at the required concentration in a 300 µL volume of PBST. SPM bead aliquots were added to the solution containing the target, and the concentration of beads was set to 2×10 6 beads/mL in the final dilution. The solution was incubated at room temperature on 15 a rotating wheel for 30 min for HSV and 2, 5 and 30 min for BBSA. After the required reaction time, the sample was subjected to magnetic field assisted aggregation, i.e., the sample containing SPMs was placed next to a NdBFe magnet with a field strength of 2.5 kGauss until the majority of the beads came out of solution.
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Once the SPMs were collected the tube was rotated 90 degrees in the magnetic field. This allowed the SPM beads to roll over each other on the side of the container.
Flow cytometry
Particle aggregation measurements were performed using a flow 25 cytometer with blue and red lasers, two light scattering detectors, and four fluorescence detectors with optical filters. The assay sample was placed into the flow cytometer instrument and the sample was analyzed until 10,000 events had been recorded (threshold in 80,000). As shown in Figure S1 (Supporting 
Results and Discussion
Detection of biotinylated bovine serum albumin (BBSA) using streptavidin functionalized SPMs
The principle of MBA-FC assay was initially investigated using the model streptavidin-biotin molecular recognition system.
45
Biotinylated bovine serum albumin (BBSA), where each BSA protein was functionalized with an average of 9 biotin molecules, was detected with highly uniform 2.8 µm streptavidin functionalized SPMs. particles, shown in Figure 2A , fell into distinct sub-populations in which the intensity of scattering was proportional to the area of scattering (as measured by FC). This allowed us to identify the 55 number density of monomers as well as dimeric, trimeric, and tetrameric aggregates, which scattered light more intensely. The use of the same number of beads for each measurement ensured that the formation of aggregates was directly related to the observed decrease in monomers, i.e., the maximum number of signal at high concentrations of BBSA resulted from the saturation of the streptavidin on the beads, which we will refer to as the 'hook' effect. It was also observed that a significant number of larger aggregates were formed at 10 -9 M BBSA concentrations, which was characteristic of the higher coverage 75 of biotin on the beads. 
where k 2 and k -2 are the forward and reverse reaction rates of the beads, respectively. The rate constants of this reaction are determined by the rate of encounter of the beads and reaction of the immobilized BBSA and streptavidin (k S-B ). The passive rate of encounter of the SPM beads in solution is inhibited by the 50 hydrodynamic resistance that results from the layer of water between the beads. However, the speed of the encounter can be significantly increased by the use of a magnetic field to force the SPM beads. Thus, the rate of this second reaction in the MBA assay would ideally be limited by k S-B , which was defined by the 55 rotational diffusion coefficient of the beads and the steric mobility of the immobilized streptavidin and biotin. The concentration at which the hook effect occurs is central to the design of a useful MBA assay, as shown in Figure 3 , as it defines the upper limit over which the analyte concentration is 60 proportional to the density of aggregates and also strongly influences the sensitivity of the assay. The hook concentration was determined by the streptavidin binding capacity of a specific density for a specific size of SPM bead (results presented in the Supplementary Information section). Curve 1 in Figure S4 65 presents the response of an MBA assay in which the streptavidin binding capacity was 7.5x10 -8 M. The maximum number of aggregates occurred at ~3x10 -9 M. When the streptavidin binding capacity was decreased to 8x10 -9 M, as shown in curve 2 in Figure S4 , the hook concentration decreased to ~3x10 -10 M.
70
Thus, the maximum number of aggregates was found to form at a BBSA concentration that is close to but less than the streptavidin binding capacity of the beads, i.e., S ≈ 0. This effect is observed in the shift in the maximum of curves 1 and 2 in Figure 3 .
75
The sensitivity of the MBA assay was determined by amount of BBSA bound to the streptavidin beads for a specific reaction time, which is defined by reaction 1 if the aggregation of the beads is highly efficient. Reaction 1 can be treated as quasifirstorder for low concentrations of BBSA if k 1 >>k -1 for the biotin-80 streptavidin reaction. Under these conditions it can be shown that the concentration of bound BBSA, C B , varies with time (t) as time the extent of reaction, and thus sensitivity of the MBA assay, can be predicted to increase for smaller reaction volumes, higher on-rates, larger surface areas, and higher surface densities of streptavidin. This theoretical analysis is consistent with the observation that the sensitivity of the MBA assay increased with 95 the density of streptavidin bound to the SPM beads, as shown by the apparent increase in sensitivity of curves 1 and 3 in Figure  S4 . This analysis also suggests that the MBA assay sensitivity will decrease at a critical density of the SPM beads, and a significant decrease was observed at bead concentrations below 100 10 6 beads/mL (results not presented).
Identification of novel anti-HSV peptides
Novel peptide-based binding reagents against purified HSV-1 were identified by screening a bacteriophage library displaying dodecapeptides and containing approximately one billion independent clones (Experimental). Figure 4A presents the endpoint binding signal, as determined by direct immuno-assay, of the amplified eluted phage pool obtained after each round of selection, using HRP-conjugated anti-pVIII monoclonal 5 antibodies (see Supporting Information). The increase in percentage of phage recognizing HSV-1 as biopanning proceeded was reflective of the enrichment of the whole population in favor of displayed peptides specific for HSV-1, and is an indication of the success of the selection procedure. Based on DNA sequencing analysis from the final round phage 25 sequencing, three peptide constructs were designed for synthesis with a C-terminal biotin moiety acting as a reporter for detection in binding experiments. Additionally, a glycine-rich spacer was included in the sequence to mimic the scenario where the peptide is fused to the phage. Figure 4B corresponds which added a unique functional group as there are no other cysteine residue present in the identified sequence. The structure of the final MAP construct used in the MBA assay is provided in Figure 4C . Figure S1 , and the distribution of monomers and aggregates is presented in curve 1 in Figures 5A and B, respectively. These results show that the number of aggregates 60 increased steadily in the presence of HSV-1 at concentrations between 2 and 2.1x10 6 vp/ml, and that a hook effect was observed in the HSV-1 response at concentrations greater than 2.1x10 6 vp/ml.
C. Detection of HSV-1 using MAP-G functionalized SPMs

MAP-G was used to perform the MBA assay for the detection of HSV-1 by immobilizing biotinylated MAP-G on streptavidin functionalized SPM beads (SPM-G1 beads, Methods
65
The background of HSV-1 SPM-G1 assays significantly influenced the sensitivities of these assays. For BBSA, the aggregates in the blank assays were determined to make-up 8% of the total beads, while for SPM-G1 almost 30% of the monomers aggregated in the absence of HSV-1. This increase in aggregation 70 was attributed to the nonspecific interaction between the MAP-G peptides and the streptavidin on the beads. In order to reduce these nonspecific interactions, streptavidin was eliminated, and a polyethylene glycol (PEG) monolayer was grafted to the surface of the SPM beads, as shown in Figure 1C . 26 The PEG 75 monolayer acts to minimize nonspecific interactions and enhanced the steric mobility of the peptide, resulting in a lower background and higher k S-b . The SPM-G2 and SPM-G3 beads were prepared by covalently grafting the peptides to a monolayer of PEG with BOG-PEG:MPEG ratios of 1:3 and 1:0, 80 respectively. Zeta-potential measurements were performed to characterize each step as a function of pH, as shown in Figure S2 , and confirm the inclusion of the PEG monolayer led to a decrease in the surface charge of the beads. The numbers of aggregates in the negative control for SPM-G2 and SPM-G3 decreased to less than 13%. The binding capacity of the SPM-G2 beads for the virus decreased somewhat, but the SPM-G3 5 construct regained almost full binding capacity with 50% of the beads aggregating at a virus concentration of 2.1x10 6 vp/mL. This is consistent with the observation that maximum sensitivities of the MBA assay are achieved for high densities of ligands on the surface of the SPM beads. Aggregates of SPM beads functionalized with other peptides and antibodies formed as a function of HSV concentration. 1 HSV-1 assays using SPM-G1 beads, 2 HSV-1 assays using SPM-N 25 beads, 3 HSV-1 assays using SPM-E beads, 4 HSV-2 assays using SPM-G1 beads, and 5 HSV-1 assays using SPM-A beads. D. Distribution of monomers as a function of HSV in the aggregation assays described in C. In each assay, the concentration of SPMs was 2x10 6 beads/mL.
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Sensitivity of HSV-1 assays using SPM-N and SPM-E beads
The multi-antigenic peptide ligands were further investigated in MBA assays by testing synthetic peptides N and E, which previously demonstrated capacity to detect HSV-1 in ELISA. Immobilization of biotinylated peptides was achieved by simple 35 incubation with streptavidin beads, and curves 2 and 3 in Figure  5C present the results of the HSV-1 MBA assay for MAP-N and MAP-E functionalized particles, respectively. Clearly, the formation of aggregates using SPM-N and SPM-E was not significant for virus concentrations over six orders of magnitude.
40
The significant difference in the binding of different peptide ligands to HSV-1 is likely due to the physico-chemical properties of the virus and peptides. In ligand-pathogen interactions, initial attraction is commonly attributed to weak forces, such as, van der Waals and electrostatic charges, enabling the reactants to come 45 into close proximity, before specific interactions begin to dominate and reinforce binding. 27 The large number of glycoprotein spikes on the surface of HSV-1 produces a strong physical barrier, inhibiting the interaction of the virus with micron scale structures such as the SPM beads. Characterization 50 of HSV-1 surface charge by zeta potential analysis suggested the viral particle has a strong negative charge, which is consistent with previous measurements. 28 Peptide G had a positive charge while peptides N and E were less charged. Additionally, it has been reported that immobilization of peptides can significantly 55 reduce peptide activity. 29 To further investigate this phenomenon the binding kinetics of MAP-N and MAP-E to HSV-1 was studied using SPR, and confirmed the inability of HIV-1 to bind to biotinylated peptides immobilized on a streptavidin sensor chip. Taken together, these observations appear to explain the 60 lack of aggregates formed using peptides N and E in the MBA assay.
Response of SPM-G1 beads for HSV-2
MBA assays using SPM-G1 beads were also performed with HSV-2 virus to determine if the construct was specific for the 65 HSV-1 strain. The assays were performed at similar conditions to the previously reported HSV-1 assays with SPM bead concentration of 2x10 6 beads/ml and HSV-2 at 1.6x10 3 , 1.6x10 5 ,
1.6x10 7 , and 1. presented in curve 4 of Figure 5C and D, respectively. Clearly, an insignificant growth of aggregates was observed until quite high virus concentrations were reached, i.e., 1.6x10 7 and1.6x10 9 vp/ml. Moreover, the hook effect, observed previously, was not observed for HSV-2. This suggests that the interaction between 5 HSV-2 and MAP-G lacks the specificity necessary to induce significant aggregation. HSV-2, therefore, is not suitable for detection by MAP-G. in the typical range for antibody-antigen interaction. The antibody was immobilized on SPM beads using protein A to enable optimal orientation and maximize interaction with the target. Curve 5 in Figure 5C presents the results of the aggregation assays using SPM-A beads at a concentration of 2 
HSV-1 assays using antibody functionalized beads
Structural analysis of SPM-G bead complexes with HSV-1
To gain an understanding of the exceptionally high sensitivity of the HSV-1 assay, the interaction of the virus with the SPM-G1 40 beads was studied with transmission electron microscopy (TEM). Initially, the HSV-1virion was examined using uranyl acetate negative staining, as shown in Figure 6A and the size of the virus was determined to be between 150 and 200 nm. Structural elements of the virus, such as the envelope, tegument, and capsid, 45 were distinguishable in these studies, and are consistent with the high-resolution cryo-TEM studies of HSV.18 Figure 6C presents an image of the surface of MAP-G modified SPM beads that were smooth down to the nanometer scale. Figure 6D present images of SPM-G1 beads after incubation with a high 50 concentration of HSV-1, fixation with glutaraldehyde, and negative staining by uranyl acetate. These images reveal objects on the surface of the beads approximately 30 to 100 nanometer in size that appear to result from the binding of the virus. Figure 6F presents a high-resolution image of the interface of two SPMs 55 after incubation with HSV-1 and application of a magnetic field. The material between the beads appears to be consistent with the aggregation of the SPM beads through interaction with HSV-1. These images confirm that the interaction of the virus with the SPM beads occur over a significant area of contact, which is 60 consistent with multivalent binding. 
Conclusions
This article has demonstrated that the MBA assay is capable of sensitive and rapid detection of proteins and the HSV-1 virus. Highly uniform SPM beads enabled the rapid detection of 75 aggregate sizes, one particle at a time, using light scattering. Biotinylated albumin was detected over six orders of magnitude for reactions times as short as 2 minutes with a sensitivity in the femtomolar range. Analysis of the kinetics of binding indicated that sensitivity of the MBA assay will increase for smaller 80 reaction volumes, higher on-rates, larger surface areas, and higher surface densities of ligand. The MBA assay was also used to detect HSV-1 at concentrations spanning six orders of magnitude. Antibodies against HSV-1 proved to be unsuitable for this MBA assay, and the identification of a novel peptide structure with high 85 affinity for HSV-1 proved crucial to the successful development of the assay. This was attributed to the complex structure of the virus, which is known to contain up to 750 glycoprotein spikes that appear to inhibit the reaction of the virus with the micron size SPM beads. Ultrastructure characterization of the SPM bead 90 interaction with HSV-1 virus suggests that the mechanism for the increased sensitivity of the virus assay was the multivalent interaction of the virus with the surface of the beads. We also report the successful reduction in monomer aggregation by use of a PEG monolayer. The lowest level of detection was 200 virus 5 particles/mL for reaction times of 30 min. The speed and sensitivity of the MBA assay were linked to the enhanced rates of reaction of an analyte with a suspension of beads and the subsequent use of a magnetic force to collect the SPM beads and accelerate bead aggregation. These results suggest that the MBA 10 assay could prove to be a powerful tool for the detection of viral infections in a point of care setting, with FC having already been implemented in a miniaturized format 30, 31 . A limitation of the MBA assay was the decrease in aggregation at high concentrations of analyte that result from the saturation of the 15 SPM bead surfaces, but this can be overcome by careful design of the assay based on the principles described in this article.
